We are live on ! Find out more
NGM

North Growth Management Portfolio holdings

AUM $780M
1-Year Est. Return 102.77%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
AUM
$469M
AUM Growth
+$18M
Cap. Flow
-$28.4M
Cap. Flow %
-6.06%
Top 10 Hldgs %
40.94%
Holding
51
New
2
Increased
9
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
ITGR icon
Integer Holdings
ITGR
+$7.92M
2
TMO icon
Thermo Fisher Scientific
TMO
+$7.74M
3
INMD icon
InMode
INMD
+$3.3M
4
SEDG icon
SolarEdge
SEDG
+$2.73M
5
ARHS icon
Arhaus
ARHS
+$2.05M

Sector Composition

Rank Sector Weight
1 Technology 44.53%
2 Consumer Discretionary 20.06%
3 Industrials 16.9%
4 Healthcare 15.08%
5 Communication Services 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
51
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-163,000
Closed -$18.9M

Similar funds

North Growth Management's Q4 2023 Portfolio in Review

As of Q4 2023, North Growth Management held 51 positions worth $469M, up 4% from $451M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

North Growth Management withdrew a net $28.4M in Q4 2023, closing 4 positions and reducing 4 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, North Growth Management opened a new position in Integer Holdings worth $9.15M.

  • North Growth Management's largest Q4 2023 buy was Integer Holdings: 92,000 shares worth $9.15M.
  • North Growth Management added most to InMode in Q4 2023, an estimated $3.3M increase.
  • North Growth Management's biggest Q4 2023 reduction was Jabil, cutting an estimated $7.13M.
  • North Growth Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $18.9M.
  • North Growth Management's ten largest holdings make up 41% of its $469M portfolio in Q4 2023.
  • North Growth Management opened 2 new positions and closed 4 in Q4 2023.
  • North Growth Management's portfolio value rose 4% quarter-over-quarter to $469M.

Based on North Growth Management's 13F filing for Q4 2023, filed 7 Feb 2024.